Beck Bode LLC’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-4,671
Closed -$204K – 145
2022
Q4
$204K Buy
+4,671
New +$198K 0.05% 146
2022
Q3
– Sell
-5,054
Closed -$214K – 227
2022
Q2
$214K Buy
+5,054
New +$220K 0.05% 173

Other funds holding BME

Beck Bode LLC's BME Position: Q1 2023 in Review

Beck Bode LLC sold out of BlackRock Health Sciences Trust (BME) in Q1 2023, closing a stake of 4,671 shares — an estimated $204K sold.

Beck Bode LLC first reported a position in BME in Q2 2022 and held it in 2 quarters. The position peaked at $214K in Q2 2022. 71 funds tracked by Wall St. Rank hold BME as of Q1 2023.

  • Beck Bode LLC reported no remaining BlackRock Health Sciences Trust position as of Q1 2023 after selling out during the quarter.
  • Beck Bode LLC sold 4,671 BlackRock Health Sciences Trust shares in Q1 2023, an estimated $204K.
  • Beck Bode LLC first reported a position in BlackRock Health Sciences Trust in Q2 2022 and held it in 2 quarters.
  • Beck Bode LLC's BlackRock Health Sciences Trust position peaked at $214K in Q2 2022.
  • 71 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2023.

Based on Beck Bode LLC's 13F filing for Q1 2023, filed 3 May 2023.